All News about Ensysce Biosciences Inc![]() ![]() ![]() ![]() ![]() Via ACCESSWIRE
![]() Via ACCESSWIRE
![]()
Ensysce Biosciences Secures $1.7 Million Convertible Note Financing
October 24, 2023
Via ACCESSWIRE
![]() ![]()
Ensysce Biosciences Issues 2024 Shareholder Letter
January 08, 2024
Via ACCESSWIRE
![]() ![]() Via ACCESSWIRE
![]() ![]() ![]() ![]() ![]() ![]()
Ensysce Biosciences Issues 2023 Shareholder Letter
January 11, 2023
Via ACCESSWIRE
![]()
Ensysce Biosciences Announces Pricing of $4.1 Million Public Offering
December 07, 2022
Via ACCESSWIRE
![]() ![]()
Ensysce Biosciences Reports Third Quarter 2022 Financial Results
November 14, 2022
Via ACCESSWIRE
![]() ![]() ![]() ![]() ![]() ![]()
Ensysce Biosciences Announces Results of Special Meeting of Stockholders
September 08, 2022
Via ACCESSWIRE
![]()
Ensysce Biosciences Reminds Shareholders to Vote at Upcoming Special Meeting
September 06, 2022
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|